Skip to main content
Log in

Dynamics of circulating microparticles in obesity after weight loss

  • IM - ORIGINAL
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

A definitive relationship between adiposity and MP production is yet to be demonstrated. The aim of our study was to prospectively evaluate the levels of microparticles (MP) in a group of 20 III degree obese patients before and after weight loss. Plasma levels of annexin V-MP, endothelial-derived MP, platelet-derived MP (CD61+ and P-Selectin+), leukocyte-derived MP, tissue factor-bearing (TF+) and CD36+MP were prospectively measured in 20 patients with III degree obesity (BMI ≥ 40 kg/m2) before (T0) and 3 (T3) and 12 (T12) months after sleeve gastrectomy (SLG). Obese patients had lost 18 % of their body weight at T3 and 41 % at T12. We find that considering all MP, except for endothelial-derived MP, which had significantly decreased at T3, all MP subtypes had significantly decreased at T12. At T12, subjects showed a higher median level of all types of MP, except endothelial-derived MP, compared to T3, but without a statistically significant difference. The percentages of reduction of all the MP were significantly correlated with the percentage of reduction of BMI. The reductions of leukocyte-derived, TF+ and CD36+MP were significantly correlated with the reduction of leptin. Moreover, the reductions of leukocyte-derived and CD36+MP were significantly correlated with hs-CRP decrease. The decrease of BMI post-SLG in morbid obesity was matched with a decrease of circulating MP of endothelial, platelet, leukocyte origin, TF+ and CD36+. A trend of slight increase in all MP subtypes, except endothelial-derived, was detected 12 months after gastrectomy, indicating a possible underlying slow low-grade inflammatory/hypercoagulability state from adipose tissue before the potential overt weight gain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Chistiakov DA, Orekhov AN, Bobryshev YV (2015) Extracellular vesicles and atherosclerotic disease. Cell Mol Life Sci 72:2697–2708

    Article  CAS  PubMed  Google Scholar 

  2. Boulanger CM, Dignat-George F (2011) Microparticles: an introduction. Arterioscler Thromb Vasc Biol 31:2–3

    Article  CAS  PubMed  Google Scholar 

  3. Martinez MC, Tual-Chalot S, Leonetti D, Andriantsitohaina R (2011) Microparticles: targets and tools in cardiovascular disease. Trends Pharmacol Sci 32:659–665

    Article  CAS  PubMed  Google Scholar 

  4. Nomura S, Shimizu M (2015) Clinical significance of procoagulant microparticles. J Intensive Care. doi:10.1186/s40560-014-0066-z

    PubMed  PubMed Central  Google Scholar 

  5. Owens AP III, Mackman N (2011) Microparticles in hemostasis and thrombosis. Circ Res 108:1284–1297

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mause SF, Weber C (2010) Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 107:1047–1057

    Article  CAS  PubMed  Google Scholar 

  7. Helal O, Defoort C, Robert S, Marin C, Lesavre N, Lopez-Miranda J, Risérus U, Basu S, Lovegrove J, McMonagle J, Roche HM, Dignat-George F, Lairon D (2011) Increased levels of microparticles originating from endothelial cells, platelets and erithrocytes in subjects with metabolic syndrome: relationship with oxidative stress. Nutr Metab Cardiovasc Dis 21:665–671

    Article  CAS  PubMed  Google Scholar 

  8. Goichot B, Grunebaum L, Desprez D, Vinzio S, Meyer L, Schlienger JL, Lessard M, Simon C (2006) Circulating procoagulant microparticles in obesity. Diabetes Metab 32:82–85

    Article  CAS  PubMed  Google Scholar 

  9. Heinrich LF, Andersen DK, Cleasby ME, Lawson C (2015) Long-term high fat feeding of rats results in increased numbers of circulating microvesicles with pro-inflammatory effects on endothelial cells. Br J Nutr 113:1704–1711

    Article  CAS  PubMed  Google Scholar 

  10. Darvall KAL, Sam RC, Silverman SH, Bradbury AW, Adam DJ (2007) Obesity and thrombosis. Eur J Vasc Endovasc Surg 33:223–233

    Article  CAS  PubMed  Google Scholar 

  11. Lorenzet R, Napoleone E, Cutrone A, Donati MB (2012) Thrombosis and obesity: cellular bases. Thromb Res 129:285–289

    Article  CAS  PubMed  Google Scholar 

  12. Samad F, Ruf W (2013) Inflammation, obesity, and thrombosis. Blood 122:3415–3422

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Campello E, Zabeo E, Radu CM, Spiezia L, Gavasso S, Fadin M, Woodhams B, Vettor R, Simioni P (2015) Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events. Thromb Haemost 113:85–96

    Article  PubMed  Google Scholar 

  14. Morel O, Luca F, Grunebaum L (2011) Short-term very low-calorie diet in obese females improves the haemostatic balance through the reduction of leptin levels, PAI-1 concentrations and a diminished release of platelet and leukocyte-derived microparticles. Int J Obes 35:1479–1486

    Article  CAS  Google Scholar 

  15. Murakami T, Horigome H, Tanaka K, Nakata Y, Ohkawara K, Katayama Y, Matsui A (2007) Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity. Thromb Res 119:45–53

    Article  CAS  PubMed  Google Scholar 

  16. Stepanian A, Bourguignat L, Hennou S, Coupaye M, Hajage D, Salomon L, Alessi MC, Msika S, de Prost D (2013) Microparticle increase in severe obesity: not ralted to metabolic syndrome and unchanged after massive loss. Obesity 21:2236–2243

    Article  CAS  PubMed  Google Scholar 

  17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419

    Article  CAS  PubMed  Google Scholar 

  18. Campello E, Spiezia L, Radu CM, Bulato C, Gavasso S, Tormene D, Woodhams B, Dalla Valle F, Simioni P (2015) Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S. Thromb Haemost 15:81–88

    Article  Google Scholar 

  19. Lacroix R, Robert S, Poncelet P, Kasthuri RS, Key NS, Dignat-George F, Workshop ISTHSSC (2010) Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on thrombosis and haemostasis SSC collaborative workshop. J Thromb Haemost 8:2571–2574

    Article  CAS  PubMed  Google Scholar 

  20. Lacroix R, Judicone C, Mooberry M, Boucekine M, Key NS, Dignat-George F, Workshop The ISTH SSC (2013) Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on thrombosis and haemostasis SSC collaborative workshop. J Thromb Haemost 11:1190–1193

    Article  Google Scholar 

  21. van Dreden P, Rousseau A, Fontaine S et al (2009) Clinical evaluation of a new functional test for detection of plasma procoagulant phospholipids. Blood Coagul Fibrinolysis 20:494–502

    Article  PubMed  Google Scholar 

  22. Campello E, Spiezia L, Radu CM, Gavasso S, Woodhams B, Simioni P (2014) Evaluation of a procoagulant phosholipid functional assay as a routine test for measuring circulating microparticle activity. Blood Coagul Fibrinolysis 25:534–537

    Article  CAS  PubMed  Google Scholar 

  23. De Pergola G, Pannacciulli N (2002) Coagulation and fibrinolyses abnomalities in obesity. J Endocrinol Invest 25:899–904

    Article  PubMed  Google Scholar 

  24. Cimenti C, Mangge H, Haidl H, Zach D, Muntean W (2006) Thrombin generation in severely obese children. J Thromb Haemost 4:1834–1836

    Article  CAS  PubMed  Google Scholar 

  25. Cheng V, Kashyap SR, Schauer PR, Kirwan JP, McCrae KR (2013) Restoration of glycemic control in patients with type 2 diabetes mellitus after bariatric surgery is associated with reduction in microparticles. Surg Obes Relat Dis 9:207–212

    Article  PubMed  Google Scholar 

  26. Thorne RF, Mhaidat NM, Ralston KJ, Burns GF (2007) CD36 is a receptor for oxidized high density lipoprotein: implications for the development of atherosclerosis. FEBS Lett 581:1227–1232

    Article  CAS  PubMed  Google Scholar 

  27. Silverstein RL (2009) Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36. Cleve Clin J Med 76:S27–S30

    Article  PubMed  PubMed Central  Google Scholar 

  28. Febbraio M, Hajjar DP, Silverstein RL (2001) CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108:785–791

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Alkhatatbeh MJ, Mhaidat NM, Enjeti AK, Lincz LF, Thorne RF (2011) The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles. J Thromb Haemost 9:844–851

    Article  CAS  PubMed  Google Scholar 

  30. Alkhatatbeh MJ, Enjeti AK, Acharya S, Thorne RF, Lincz LF (2013) The origin of circulating CD36 in type 2 diabetes. Nutr Diabetes. doi:10.1038/nutd.2013.1

    PubMed  PubMed Central  Google Scholar 

  31. Connor DE, Exner T, Ma DD, Joseph JE (2010) The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost 103:1044–1052

    Article  CAS  PubMed  Google Scholar 

  32. Arraud N, Gounou C, Turpin D, Brisson AR (2015) Fluorescence triggering: a general strategy for enumerating and phenotyping extracellular vesicles by flow cytometry. Cytometry. doi:10.1002/cyto.a.22669 (Epub ahead of print)

    PubMed  Google Scholar 

  33. Shantsila E, Montoro-García S, Gallego P, Lip GY (2014) Circulating microparticles: challenges and perspectives of flow cytometric assessment. Thromb Haemost 111:1009–1014

    Article  CAS  PubMed  Google Scholar 

  34. Lacroix R, Dubois C, Leroyer AS, Sabatier F, Dignat-George F (2013) Revisited role of microparticles in arterial and venous thrombosis. J Thromb Haemost 11:24–35

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elena Campello.

Ethics declarations

Conflict of interests

The authors declare that they have no conflict of interest.

Statement of human and animal rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the author.

Informed consent

Each patient considered for the study gave his/her personal informed consent at the time of enrollment.

Additional information

E. Campello and E. Zabeo have contributed to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Campello, E., Zabeo, E., Radu, C.M. et al. Dynamics of circulating microparticles in obesity after weight loss. Intern Emerg Med 11, 695–702 (2016). https://doi.org/10.1007/s11739-016-1397-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-016-1397-7

Keywords

Navigation